Company / Current Liabilities per Share
Serina Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.42
FY2025
5-year range
$0.24 / $1.31
FY2021-FY2025
Trend
-56.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.31 to $0.42 over the past 2 years.
Based on SEC 10-K filings.
0.42 in FY2025 with a 5-year CAGR of +24.4%.
Improved from $1.31 to $0.42 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +16.8%
- 5-Year CAGR
- +24.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 56.9% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | -56.9% |
| FY2024 | $0.98 | -25.0% |
| FY2023 | $1.31 | +393.0% |
| FY2022 | $0.27 | +11.6% |
| FY2021 | $0.24 | +67.2% |
| FY2020 | $0.14 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026